readthroughSign in
CompanyCUENasdaqBoston, MA

Cue Biopharma, Inc.

Cue Biopharma develops therapies for immunological disorders using its Immuno-STAT platform to target disease-specific T cells.

10-QNov 16Latest SEC filing
Nov 16Latest story